Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amanta HealthcareNSE:AMANTA -2.00%14 Days Payable is 113.46 as of Mar. 2026, which is 9% below its 10-year median of 125.37. GuruFocus rates NSE:AMANTA with a GF Score™ of 14/100. The stock has 4 warning signs investors should review. Among 927 Drug Manufacturers companies, Amanta Healthcare ranks better than 77.45% on this metric.
The historical rank and industry rank for Amanta Healthcare's Days Payable or its related term are showing as below:
NSE:AMANTA'
s Days Payable Range Over the Past 10 Years
Min: 101.52 Med: 125.37 Max: 177.54
Current: 159.16
During the past 5 years, Amanta Healthcare's highest Days Payable was 177.54. The lowest was 101.52. And the median was 125.37.
NSE:AMANTA's Days Payable is ranked better than 77.45% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs NSE:AMANTA: 159.16
Amanta Healthcare's Days Payable
declined
from Dec. 2024 (127.82) to Mar. 2026 (113.46).
It may suggest that Amanta Healthcareaccelerated paying its suppliers.
Amanta Healthcare Days Payable Related Terms
Amanta Healthcare Days Payable Historical Data
* Premium members only.
The historical data trend for Amanta Healthcare's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Amanta Healthcare's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amanta Healthcare Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Amanta Healthcare's Days Payable distribution charts can be found below:
* The bar in red indicates where Amanta Healthcare's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Amanta Healthcare's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amanta Healthcare (NSE:AMANTA) has a Days Payable of 113.46 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Amanta Healthcare and its competitors. This is near median its historical median of 125.37. Over the past decade, Amanta Healthcare's Days Payable has ranged from 101.52 to 177.54. According to the industry distribution chart, Amanta Healthcare ranks #209 out of 927 companies in the Drug Manufacturers industry, placing it in the top 22.5%.
Is Amanta Healthcare's Days Payable too high?
Amanta Healthcare's current Days Payable of 113.46 is near median its 10-year median of 125.37. Over the past 10 years, this metric has ranged from a low of 101.52 to a high of 177.54. The Drug Manufacturers industry median Days Payable is 90.38. Amanta Healthcare's value of 113.46 is 25.5% above this industry median. Based on the distribution chart, Amanta Healthcare ranks #209 out of 927 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Amanta Healthcare has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Amanta Healthcare's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Amanta Healthcare ranks #209 out of 927 companies for Days Payable. This places Amanta Healthcare in the top 23% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.38. Amanta Healthcare's value of 113.46 is 25.5% above this benchmark. Historically, Amanta Healthcare's own Days Payable has ranged from 101.52 to 177.54 over the past decade. While the company's 10-year median is 125.37 vs. the industry median of 90.38, Amanta Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amanta Healthcare's current Days Payable of 113.46 is 25.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Amanta Healthcare and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amanta Healthcare's current Days Payable is 113.46, which is near median its own 10-year median of 125.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amanta Healthcare stock overvalued right now?
Amanta Healthcare (NSE:AMANTA) has a current Days Payable of 113.46. The current Days Payable is 113.46, which is near median its 10-year median of 125.37 and 25.5% above the Drug Manufacturers industry median of 90.38. Amanta Healthcare's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Amanta Healthcare (NSE:AMANTA), the current Days Payable is 113.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Amanta Healthcare Ltd is a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products - parenteral products, being packed in plastic container with Aseptic Blow-Fill-Seal and Injection Strech Blow Moulding technology. It manufactures large volume parenterals and small volume parenterals in six therapeutic segments. It also manufactures medical devices. The company manufactures fluid therapy, formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products like irrigation, first-aid solution, eye lubricants etc. in medical device segment. It offers wide range of closure systems, such as nipple head, twist-off, leur-lock and screw types and container fill-volume till 1000 ml.
14GF Score
Get the complete analysis for NSE:AMANTA
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AMANTA has been successfully added to your 
